Goodbye 4$ imho, only a matter of hours.Love the active CEO's that provide precise updates and timelines. As a shareholder, I find it important having a certain minimum of transparancy.
Nothing shocking here, simply little hints how things are going and what the next steps are.
Now the forward looking news go like this :
- CSA approval (short term, matter of weeks I believe)
- Grants and Government funds (short term, Gov has to move quickly in finding innovative solutions. Masks won't save the day)
- Contracts, licences with distributors, Foreign sales.
- Manufacturing milestones, increase in production, and ability to quickly produce and deliver BioClouds.
Patent is the next goal here I believe, I don't see this a game breaker.
Cheers!
David